Substudy on the Mechanistic Plausibility of the Clinical Benefits of Adaptive Servo-ventilation

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 312 participants.

Also called NCT01164592

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 312 participants (enrolled count) (from the registry)
Sponsor
  • ResMed Registry lists this organization as the lead sponsor
Registry
  • NCT NCT01164592
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Australia, Czechia, Finland, France, Germany, Netherlands, Switzerland, United Kingdom (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01164592. Randomized; no masking; primary purpose treatment. Start 2012-08 (registry gives no type); primary completion 2015-04 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Substudy on the Mechanistic Plausibility of the Clinical Benefits of Adaptive Servo-ventilation
Acronym
MS
Condition
Heart Failure
Condition
Sleep Disorder
Condition
Cheyne Stokes Respiration
Intervention (Device)
adaptive servoventilation (ASV)
Lead sponsor
ResMed (class: industry)

Record details

Record id
cardio:ct-nct01164592
Content hash
6744d98aa8fe45df8838615c31e6df98abec1b01a52e75357810c07866098423